Company: AEGOF
Filing Date: 2025-05-16
Form Type: 6-K
Source: 0001193125-25-121236
Chunk: 74

Company: AEGON LTD.
Filing Date: 2025-05-16
Form: 6-K
Chunk 74
---
.4 Confirmation that insurance Group’s eligible capital is subject to transitional arrangements as required under the eligible capital rules Following the redemption of EUR 700 million of grandfathered Tier 2 securities on April 25, 2024, Aegon has redeemed all outstanding grandfathered Tier 2 securities. The remaining grandfathered securities now consist entirely of Aegon’s junior perpetual capital securities and perpetual cumulative subordinated bonds, which are grandfathered as restricted Tier 1 for up to 10 years as of January 1, 2016. Some or all of the remaining grandfathered instruments may continue to be outstanding beyond the end of the grandfathering period, which ends on January 1, 2026. The timing and extent of any potential replacement will be subject to the development of Aegon’s solvency position with and without grandfathered capital securities and the development of unrestricted Tier 1 and SCR, both under normal and stressed market conditions. Aegon’s debt structure and funding decisions are driven by economic considerations, also taking into account investor expectations, market circumstances, regulatory requirements, and rating agency considerations. E.1.5 Identification of any factors of the insurance Group affecting encumbrances availability and transferability of capital to meet the SCR Any surplus related to the UK With-Profit Sub-Fundof Scottish Equitable plc is restricted, as these funds are not available to the Group but are a benefit for the policyholders. There is also a fungibility restriction on the own funds related to the charitable trusts in the Americas as the local Supervisory Authority could limit the upstream to the Group, and therefore is excluded from the Group Own Funds. Per 4Q 2024 it has been decided to cap the ATHTF (China insurance joint venture) contribution to Group solvency at 100% of its core SCR ratio. This was driven by fungibility considerations in the context of the current low China interest rates.

| 56 |     | | Aegon Financial Condition Report 2024 |

| Capital management  Regulatory capital requirements |

E.1.6 Identification of ancillary capital instruments that have been approved by the authority The year-end2024 Solvency position of Aegon Group did not include any ancillary Own Funds as defined in Article 89(1) of Directive 2009/138/EC. E.1.7 Identification of differences in shareholder’s equity as stated in the financial statement versus available statutory capital and surplus Reconciliation shareholders’ equity - own funds